Mavacamten
Back to searchMolecule Structure
Scientific Name
Mavacamten
Description of the Drug
Mavacamten is a myosin inhibitor used to treat obstructive hypertrophic cardiomyopathy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14921
http://www.drugbank.ca/drugs/DB14921
Brand Name(s)
Camzyos
Company Owner(s)
Myokardia Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cardiac myosin | PROTEIN COMPLEX | INHIBITOR | CHEMBL3831286 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16320785 |
| PharmGKB | PA166272922 |
| DrugBank | DB14921 |
| PubChem | 117761397 |
| ChemicalBook | CB23170382 |
| Guide to Pharmacology | 11265 |
